CSPC Innovation Stock Hits Day Low of CNY 40.55 Amid Price Pressure

CSPC Innovation Pharmaceutical Co., Ltd. experienced a significant decline today, with its stock price dropping by 6.12% to reach an intraday low of CNY 40.55. This performance contrasts sharply with the China Shanghai Composite, which saw a modest gain of 1.36% on the same day. Over the past week, CSPC's stock has decreased by 3.1%, and its monthly performance reflects a more substantial decline of 19.68%. Despite a strong year-to-date performance of 53.97%, the company has faced challenges, including a 5.88% drop in net sales reported in March, contributing to negative results for six consecutive quarters. Financial metrics indicate a concerning trend, with a pre-tax profit of CNY -125.62, reflecting a staggering decline of 129.69%. Additionally, net profit has fallen dramatically by 300.62%, and the company reported a negative EBITDA, suggesting ongoing financial difficulties. CSPC's market capitalization stands at CNY 62,266 million, positioning it as a large-cap player in the FMCG industry, but its current financial indicators raise questions about its stability and growth prospects.